ARCHIVES

Blazing the Pathways: Informatics Platform Provides Foundation for “Center Without Walls”

This article is from The Cancer Letter archive.

Vol. 39 No. 02 | January 11, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

Review Panel: NCI Intramural Program Is Too Large, Redundant, Hierarchical

May 19, 1995

Also in this 8-page Issue: Safety Warnings Are Added to Labels for Epo and Avastin.

January 21, 2005

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003

NCI to Press FDA For Quicker Drug Approval, Relaxation Of Survival Impact Requirement

June 26, 1987

Phase II Trial of BIND-014 Shows Anti-Tumor Activity in Q3W Arm

November 28, 2014